ImmunityBio (IBRX) Deferred Taxes (2015 - 2021)
ImmunityBio (IBRX) reported Deferred Taxes of -$8000.0 for Q4 2021, up 96.14% year-over-year from -$4078.8 in Q4 2020, and up 96.14% quarter-over-quarter from -$207000.0 in Q4 2020.
ImmunityBio (IBRX) Deferred Taxes (2015 - 2021) Analysis & Trends
ImmunityBio (IBRX) has 7 years of Deferred Taxes data on file, last reported at -$8000.0 in Q4 2021.
- Deferred Taxes for Q4 2021 came in at -$8000.0, up 96.14% year-over-year; the trailing twelve-month figure through Dec 2021 was -$8000.0 (up 99.73% YoY), and the FY2022 annual result was -$4000.0, up 50.0% from the prior year.
- Deferred Taxes climbed to -$8000.0 in Q4 2021 per IBRX's latest filing, from -$207000.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $38000.0 in Q2 2020 and troughed at -$1.7 million in Q3 2020.
- A 5-year average of -$282071.4 and a median of -$124000.0 in 2017 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2020 and 2021: Deferred Taxes sank 2487.5% in 2020, then jumped 96.14% in 2021.
- A 5-year view of Deferred Taxes shows it stood at -$182000.0 in 2017, then soared by 32.97% to -$122000.0 in 2018, then soared by 93.44% to -$8000.0 in 2019, then slumped by 2487.5% to -$207000.0 in 2020, then jumped by 96.14% to -$8000.0 in 2021.
- Business Quant data shows IBRX's Deferred Taxes at -$8000.0 in Q4 2021, -$207000.0 in Q4 2020, and -$1.7 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | ImmunityBio | 7.55 Bn | 7.17 Bn | 43.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -8,000.00 |
| Dec 31, 2020 | -207,000.00 |
| Sep 30, 2020 | -1.70 Mn |
| Jun 30, 2020 | 38,000.00 |
| Mar 31, 2020 | -1.07 Mn |
| Dec 31, 2019 | -8,000.00 |
| Dec 31, 2018 | -122,000.00 |
| Sep 30, 2018 | -128,000.00 |
| Jun 30, 2018 | -124,000.00 |
| Mar 31, 2018 | -124,000.00 |
| Dec 31, 2017 | -182,000.00 |
| Sep 30, 2017 | -98,000.00 |
| Jun 30, 2017 | -124,000.00 |
| Mar 31, 2017 | -93,000.00 |
| Dec 31, 2016 | -152,000.00 |
| Sep 30, 2016 | -50,000.00 |
| Jun 30, 2016 | -228,000.00 |
| Mar 31, 2016 | -145,000.00 |
| Dec 31, 2015 | -302,000.00 |